$BSX BOSTON SCIENTIFIC HAS TROUBLE AHEAD.

Yesterdays enforcement by the FDA for BSX to remove one of its products from the market is a significant blow to BSX and has sent investors running scared. Fears from legal actions by clients are a definite and real possibility which will send the price into further correction in out opinion.